Takano Toru, Amino Nobuyuki
Department of Laboratory Medicine, Osaka University Graduate School of Medicine D2, 2-2 Yamadaoka, Suita, Osaka, Japan.
Thyroid. 2005 May;15(5):432-8. doi: 10.1089/thy.2005.15.432.
Modern advances in molecular technology have given us the chance to establish a new insight into thyroid carcinogenesis. Gene expression in thyroid malignancies usually reveals highly consistent profiles, which leads to questioning of the classic concept of multistep carcinogenesis, in which cancer cells are produced from well-differentiated benign cells by transformation caused by accumulating damage to their genome. We propose a novel hypothesis of thyroid carcinogenesis, the fetal cell carcinogenesis hypothesis, in which cancer cells are derived from the remnants of three types of fetal thyroid cells, instead of normal thyroid follicular cells. This hypothesis explains well the clinical and biologic features and recent molecular evidence of thyroid carcinoma. It suggests the importance of clarifying the molecular mechanism of thyroid development and the identification of fetal thyroid cells, especially thyroid stem cells (TSCs), because such data will lead to better understanding of thyroid carcinogenesis and thyroid regeneration.
分子技术的现代进展使我们有机会对甲状腺癌发生机制有新的认识。甲状腺恶性肿瘤中的基因表达通常呈现出高度一致的特征,这引发了对经典多步骤致癌概念的质疑,在经典概念中,癌细胞是由基因组累积损伤导致的转化作用,从分化良好的良性细胞产生的。我们提出了一种新的甲状腺癌发生假说,即胎儿细胞癌发生假说,其中癌细胞源自三种胎儿甲状腺细胞的残余物,而非正常甲状腺滤泡细胞。这一假说很好地解释了甲状腺癌的临床和生物学特征以及近期的分子证据。它表明了阐明甲状腺发育分子机制以及识别胎儿甲状腺细胞,尤其是甲状腺干细胞(TSCs)的重要性,因为这些数据将有助于更好地理解甲状腺癌发生和甲状腺再生。